Patients and clinical trial subjects have limited access to biosensing devices, and privacy concerns limit the use and sharing of biosensing data.
Goals and Objectives
Better utilization of biosensing data will provide more accurate patient data for condition monitoring by providers, clinical trial results for drug trials, and RWE for pharma companies.
Leverage social media and patient advocacy groups to recruit eligible patients.
Use social media to increase trial awareness and opportunities.
Increase patient awareness of industry efforts and goals in areas of medical
Cloud, mobile, social, IoT, analytics, AI, and next-generation security
Use Case Summary
Secure biosensing data that may be deidentified for individual patients or acquired via opt-in sharing by patients and trial subjects will improve medical and prescription adherence, RWE, and trial quality.
More “consumer like” engagement will recruit and retain patients in trials.